JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
March 28, 2024 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the publication of...
JenaValve’s Trilogy THV System Highlighted at CRT 2024
March 19, 2024 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the...
JenaValve Featured at the PCR London Valves 2023
December 06, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from PCR...
JenaValve Announces Partnership with the American Society of Echocardiography (ASE) to Advance Detection and Diagnosis of Aortic Regurgitation
November 16, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that it will join the...
JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
October 24, 2023 17:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from the...
JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023
September 19, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that data from the...
JenaValve Appoints Shlomi Nachman to Board of Directors
September 14, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced...
JenaValve Announces First Trilogy Heart Valve Systems Implanted in Asia
May 18, 2023 16:05 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced the...
JenaValve Appoints Ken MacLeod, Ph.D. to Board of Directors
April 05, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced...
JenaValve Appoints Dan Dearen to Board of Directors
January 05, 2023 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that...